Tag: Jayme-Strauss

2 articles

Market Moves

Precision Neuroscience hires two Nevro veterans for its commercial push

Precision Neuroscience has named Nevro founder Konstantinos Alataris as president and Katherine Neuenfeldt, who led the US launch of Nevro's spinal cord stimulator and its insurance coverage work, as senior vice president of commercial strategies. The appointments, announced on 15 October 2026, follow a $250 million Series D. Neuenfeldt is the third executive hired to lead commercial work at Precision since 2024, after Jayme Strauss and John Woock.

Oct 18

Industry News

Precision Neuroscience demonstrates thought-based gaming in non-paralysed volunteers

On Tuesday 21 July 2026, Precision Neuroscience announced that neurosurgical patients without paralysis, temporarily implanted with its Layer 7 subdural microelectrode array during scheduled tumor or epilepsy-monitoring procedures, controlled cursors and played Mario Kart, Pong and Fruit Ninja, scrolled Instagram, and answered FaceTime calls with their thoughts. Chief clinical officer Jayme Strauss confirmed the array is removed at bedside in under five minutes at the end of each participant's hospital stay, with the first permanent implant targeted for early 2028.

Jul 21

Stay Ahead of the Curve

Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.

No spam. One-click unsubscribe. We respect your privacy.